What a British Medical Journal study on 32,602 patients reveals about ibuprofen and cardiovascular risk
Most people reach for ibuprofen or a similar painkiller without a second thought — for headaches, joint pain, training-related soreness, or the everyday aches of an active life over 50. In the UK alone, approximately 9 million people take non-steroidal anti-inflammatory drugs daily.
The research on what regular NSAID use does to the heart is not widely known. It should be.
Researchers using a database of Danish patients identified 32,602 people with a first diagnosis of atrial fibrillation — commonly known as heart flutter — between 1999 and 2008. Their analysis of NSAID use across this cohort produced findings that were published in the British Medical Journal and prompted calls from the lead author for cardiovascular risk warnings to be explicitly added to NSAID prescribing guidelines.
Ibuprofen users were 40 to 70% more likely to develop atrial fibrillation than non-users.
New NSAID users showed the strongest association — a 40 to 70% relative risk increase for atrial fibrillation compared to non-users.
Approximately 9 million people in Britain take non-aspirin NSAIDs every day — making the population-level implications of these findings significant.
"Our study adds evidence that atrial fibrillation or heart flutter needs to be added to the cardiovascular risks under consideration when prescribing NSAIDs."
Professor Henrik Sorensen — lead author, British Medical Journal studyAtrial fibrillation — an irregular heart rhythm — is not a minor concern. It commonly leads to stroke and heart failure, and it affects over 700,000 people in the UK. The Danish study's finding that NSAID use is independently associated with increased atrial fibrillation risk is not a fringe result. It was published in one of the world's most rigorously peer-reviewed medical journals and has since been supported by subsequent research.
The BMJ study is not the only research pointing in this direction. Additional findings from independent studies paint a consistent picture of cardiovascular risk associated with regular NSAID use.
Three independent findings — consistent direction.
For the trainee over 50 who regularly uses ibuprofen to manage joint soreness, training aches, or chronic pain — these findings are directly relevant. NSAIDs are not aspirin. They are not universally safe at the doses and frequencies that many people assume are harmless. The evidence suggests the threshold for meaningful cardiovascular risk is lower than most people realise.
Training that is brief, well-recovered, and appropriate for the individual's recovery capacity produces far less joint stress than high-volume conventional programmes — reducing the need for daily pain management in the first place. This is one of the less-discussed practical benefits of the approach behind the Minimum Effective Strength System.
Biotechnology pioneer and bestselling author Barry Sears addressed the risks of both aspirin and NSAIDs directly in The Anti-Aging Zone, framing the problem in terms that move beyond the cardiovascular risk data alone.
Over 10,000 deaths per year associated with aspirin overuse in the United States alone.
Sears's argument is that aspirin and NSAIDs function by inhibiting prostaglandin synthesis — suppressing the inflammatory prostaglandins that cause pain, but simultaneously suppressing the protective prostaglandins that maintain the stomach lining. Extended use therefore carries a risk of internal bleeding that compounds alongside the cardiovascular risks documented by the Danish study. His position, detailed extensively in The Anti-Aging Zone, is that long-term aspirin and NSAID use creates a set of risks that most regular users are not aware of when they reach for the packet.
Continued use of NSAIDs generates the same problems as long-term aspirin use — the prostaglandin suppression that relieves pain also removes the protective mechanisms the body depends on for stomach health.
Barry Sears — The Anti-Aging ZoneNone of this research suggests that occasional painkiller use for a genuine acute injury is dangerous. The risks documented in these studies relate primarily to regular, habitual use — the daily or near-daily reliance on NSAIDs to manage chronic pain or training soreness that many active people over 50 have quietly adopted.
The practical response for trainees is twofold. First, be aware that the cardiovascular risks associated with regular NSAID use are real, documented, and relevant to the over-50 trainee in particular. Second, address the root cause of chronic training soreness — which in most cases is overtraining, inadequate recovery, or movement quality issues — rather than managing the symptom with regular medication. A training programme that does not require daily pain management to sustain is, by definition, a better programme.
For further context on cardiovascular health and the protective effects of strength training — see the exercise and high blood pressure and weight training after 50 pages.
This page presents published research on the cardiovascular risks associated with NSAID use. It is not medical advice. If you have concerns about painkiller use and your cardiovascular health, or if you are managing a chronic pain condition, please consult your doctor or pharmacist before making any changes to your medication.
Training that protects the joints, manages recovery intelligently, and produces results without grinding the body down is the practical alternative to chronic pain management. The Minimum Effective Strength System is built around exactly this approach.